Evidence map›Paper›PMID 25433089›Full record

ArticleMolecular & cellular proteomics : MCP2014

Bayesian proteoform modeling improves protein quantification of global proteomic measurements.

Bobbie-Jo M Webb-Robertson, Melissa M Matzke, Susmita Datta, Samuel H Payne, Jiyun Kang, Lisa M Bramer, Carrie D Nicora, Anil K Shukla, Thomas O Metz, Karin D Rodland and 5 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bobbie-Jo M Webb-RobertsonFrom the ‡Applied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, WA 99354; bj@pnnl.gov.
Melissa M Matzke§Computational Biology & Bioinformatics, Pacific Northwest National Laboratory, Richland, WA 99354;
Susmita Datta¶Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40202;
Samuel H Payne‖Omics Technology Development and Production, Pacific Northwest National Laboratory, Richland, WA 99354;
Jiyun Kang‖Omics Technology Development and Production, Pacific Northwest National Laboratory, Richland, WA 99354;
Lisa M BramerFrom the ‡Applied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, WA 99354;
Carrie D Nicora‖Omics Technology Development and Production, Pacific Northwest National Laboratory, Richland, WA 99354;
Anil K Shukla‖Omics Technology Development and Production, Pacific Northwest National Laboratory, Richland, WA 99354;
Thomas O Metz¶¶Omics Biological Applications, Pacific Northwest National Laboratory, Richland, WA 99354;
Karin D Rodland‡‡Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354.
Richard D Smith‡‡Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354.
Mark F TardiffFrom the ‡Applied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, WA 99354;
Jason E McDermott§Computational Biology & Bioinformatics, Pacific Northwest National Laboratory, Richland, WA 99354;
Joel G Pounds‡‡Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354.
Katrina M Waters‡‡Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354.

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Adv.Proteomics & Metabolomics:Type 2 Diabet & Pre-DiabetR33DK071283 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2007 to 2009
$1.6M
Interactive Informatics Resource for Research-driven Cancer ProteomicsU01CA184783 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI WEBB-ROBERTSON, BOBBIE-JO MARY · 2014 to 2016
$1.3M
Adv.Proteomics &Metabolomics:Type 2 Diabet &Pre-DiabetR21DK071283 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2005 to 2006
$656k
Identification of Proteins from Mass Spectrometry Data: A Statistical ApproachR15CA170091 · NCI · UNIVERSITY OF LOUISVILLE · PI KONG, MAIYING · 2013 to 2013
$464k
NCI NIH HHS R15 CA170091NCI NIH HHS U01-1CA184783NCI NIH HHS U01 CA184783NIDDK NIH HHS DK071283NIDDK NIH HHS R21 DK071283NIDDK NIH HHS R33 DK071283NIGMS NIH HHS 8 P41 GM103493-10NIGMS NIH HHS P41 GM103493PHS HHS U54-016015
6 · The paper itself

Abstract

As the capability of mass spectrometry-based proteomics has matured, tens of thousands of peptides can be measured simultaneously, which has the benefit of offering a systems view of protein expression. However, a major challenge is that, with an increase in throughput, protein quantification estimation from the native measured peptides has become a computational task. A limitation to existing computationally driven protein quantification methods is that most ignore protein variation, such as alternate splicing of the RNA transcript and post-translational modifications or other possible proteoforms, which will affect a significant fraction of the proteome. The consequence of this assumption is that statistical inference at the protein level, and consequently downstream analyses, such as network and pathway modeling, have only limited power for biomarker discovery. Here, we describe a Bayesian Proteoform Quantification model (BP-Quant)(1) that uses statistically derived peptides signatures to identify peptides that are outside the dominant pattern or the existence of multiple overexpressed patterns to improve relative protein abundance estimates. It is a research-driven approach that utilizes the objectives of the experiment, defined in the context of a standard statistical hypothesis, to identify a set of peptides exhibiting similar statistical behavior relating to a protein. This approach infers that changes in relative protein abundance can be used as a surrogate for changes in function, without necessarily taking into account the effect of differential post-translational modifications, processing, or splicing in altering protein function. We verify the approach using a dilution study from mouse plasma samples and demonstrate that BP-Quant achieves similar accuracy as the current state-of-the-art methods at proteoform identification with significantly better specificity. BP-Quant is available as a MatLab® and R packages.

Indexed as

Protein Processing, Post-TranslationalSoftwareAlternative SplicingAmino Acid SequenceAnimalsBayes TheoremBlood ProteinsHumansMiceMolecular Sequence DataProteomeProteomicsBlood ProteinsProteome

Identifiers

PMID25433089
PMCPMC4256511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.